A terapêutica antitrombótica: atual e em desenvolvimento

  • Ana Afonso Serviço de Angiologia e Cirurgia Vascular, Hospital Garcia de Orta, Almada, Portugal
  • Gil Marques Serviço de Angiologia e Cirurgia Vascular, Hospital Garcia de Orta, Almada, Portugal
  • Ana Gonçalves Serviço de Angiologia e Cirurgia Vascular, Hospital Garcia de Orta, Almada, Portugal
  • Pedro Barroso Serviço de Angiologia e Cirurgia Vascular, Hospital Garcia de Orta, Almada, Portugal
  • Antonio Gonzalez Serviço de Angiologia e Cirurgia Vascular, Hospital Garcia de Orta, Almada, Portugal
  • Hugo Rodrigues Serviço de Angiologia e Cirurgia Vascular, Hospital Garcia de Orta, Almada, Portugal
  • Maria José Ferreira Serviço de Angiologia e Cirurgia Vascular, Hospital Garcia de Orta, Almada, Portugal

Abstract

Thrombosis is one of the major causes of death worldwide. Continous increase in the knowledge about the pathophysiological changes associated with thrombosis led to the development of effective therapies (anti-platelet, anticoagulant and fibrinolytics) for the prevention and treatment of the thromboembolic disease.


However, better understanding of the underlying processes is still crucial for the development of more effective and safer antithrombotic drugs.


The aim of this review is summarize the current treatment, as well as the new agentes and to highlight their proven or possible role in Vascular Surgery.

Published
Nov 22, 2016
How to Cite
AFONSO, Ana et al. A terapêutica antitrombótica: atual e em desenvolvimento. Angiologia e Cirurgia Vascular, [S.l.], v. 12, n. 3, p. 170-179, nov. 2016. ISSN 2183-0096. Available at: <http://acvjournal.com/index.php/acv/article/view/3>. Date accessed: 19 oct. 2017.
Section
Review Article